Home > Income Statement > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
Revenue

    Back to Income Statement
SAMRAT PHARMACHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

SAMRAT PHARMACHEM Last 5 Year Revenue History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹286 Cr₹282 Cr₹311 Cr₹222 Cr₹179 Cr

What is the latest Revenue of SAMRAT PHARMACHEM ?

The latest Revenue ratio of SAMRAT PHARMACHEM is ₹286 Cr based on Mar2025 Standalone results.
Year Revenue
Mar2025₹286 Cr
Mar2024₹282 Cr
Mar2023₹311 Cr
Mar2022₹222 Cr
Mar2021₹179 Cr

How is Revenue of SAMRAT PHARMACHEM Trending?

Years Revenue % Change
Mar2025 ₹286 Cr
1.52
Mar2024 ₹282 Cr
-9.36
Mar2023 ₹311 Cr
40.09
Mar2022 ₹222 Cr
23.87
Mar2021 ₹179 Cr -

Compare Revenue of peers of SAMRAT PHARMACHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM ₹63.1 Cr -2.4% -2.8% -38.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,613.0 Cr 0.9% 6.2% 0.6% Stock Analytics
DIVIS LABORATORIES ₹167,105.0 Cr 1.8% 4.8% 6.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,926.0 Cr 1.3% 9.8% 37.7% Stock Analytics
DR REDDYS LABORATORIES ₹109,088.0 Cr 1.7% 5.8% 6.7% Stock Analytics
CIPLA ₹107,120.0 Cr -1.3% 0.9% -8.9% Stock Analytics


SAMRAT PHARMACHEM Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM

-2.4%

-2.8%

-38.8%

SENSEX

0%

1.2%

9.7%


You may also like the below Video Courses